List of Regenexx Corporate patents | 5 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10898497 Compositions and methods for cartilage repair	Patent 10898497 was granted and assigned to Regenexx Corporate on January, 2021 by the United States Patent and Trademark Office.		Regenexx Corporate	United States Patent and Trademark Office	10898497	January 26, 2021
‌ US Patent 11278573 Methods and compositions to facilitate repair of avascular tissue	Patent 11278573 was granted and assigned to Regenexx Corporate on March, 2022 by the United States Patent and Trademark Office.		Regenexx Corporate	United States Patent and Trademark Office	11278573	March 22, 2022
‌ US Patent 10905721 Device and methods for platelet lysis or activation	Patent 10905721 was granted and assigned to Regenexx Corporate on February, 2021 by the United States Patent and Trademark Office.		Regenexx Corporate	United States Patent and Trademark Office	10905721	February 2, 2021
‌ US Patent 9976115 Bone marrow adipose portion isolation device and methods	Patent 9976115 was granted and assigned to Regenexx Corporate on May, 2018 by the United States Patent and Trademark Office.		Regenexx Corporate	United States Patent and Trademark Office	9976115	May 22, 2018
‌ US Patent 10537596 Bone marrow adipose portion isolation device and methods	Patent 10537596 was granted and assigned to Regenexx Corporate on January, 2020 by the United States Patent and Trademark Office.	Regenexx Corporate	Regenexx Corporate	United States Patent and Trademark Office	10537596	January 21, 2020